Free Trial

Haleon PLC Sponsored ADR (NYSE:HLN) Given Consensus Rating of "Moderate Buy" by Brokerages

Haleon logo with Medical background

Shares of Haleon PLC Sponsored ADR (NYSE:HLN - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eleven brokerages that are presently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $12.33.

HLN has been the topic of several analyst reports. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 target price on the stock in a report on Friday, May 9th. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a report on Tuesday, May 27th. BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 target price on the stock in a report on Tuesday, May 27th. Barclays reiterated an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. Finally, Wall Street Zen upgraded shares of Haleon from a "hold" rating to a "buy" rating in a research note on Friday, June 6th.

Read Our Latest Research Report on HLN

Haleon Trading Up 0.9%

Shares of Haleon stock opened at $10.36 on Friday. Haleon has a 1 year low of $8.41 and a 1 year high of $11.42. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.78 and a current ratio of 0.98. The company has a market capitalization of $46.54 billion, a P/E ratio of 26.55, a PEG ratio of 2.92 and a beta of 0.25. The company's fifty day moving average is $10.72 and its two-hundred day moving average is $10.15.

Institutional Trading of Haleon

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Farther Finance Advisors LLC raised its position in Haleon by 8.8% during the first quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company's stock worth $131,000 after acquiring an additional 1,041 shares during the last quarter. Apollon Wealth Management LLC raised its position in Haleon by 5.4% during the first quarter. Apollon Wealth Management LLC now owns 21,722 shares of the company's stock worth $224,000 after acquiring an additional 1,111 shares during the last quarter. Simplicity Wealth LLC raised its position in Haleon by 7.9% during the first quarter. Simplicity Wealth LLC now owns 15,482 shares of the company's stock worth $159,000 after acquiring an additional 1,135 shares during the last quarter. Holistic Financial Partners raised its position in Haleon by 9.6% during the first quarter. Holistic Financial Partners now owns 13,379 shares of the company's stock worth $138,000 after acquiring an additional 1,172 shares during the last quarter. Finally, AE Wealth Management LLC raised its position in Haleon by 6.5% during the first quarter. AE Wealth Management LLC now owns 19,323 shares of the company's stock worth $199,000 after acquiring an additional 1,186 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Company Profile

(Get Free Report

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Recommended Stories

Analyst Recommendations for Haleon (NYSE:HLN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Haleon Right Now?

Before you consider Haleon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.

While Haleon currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines